#1#2Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this earnings presentation are forward-looking statements. In some cases, we have identified forward-looking statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. These forward-looking statements, which are subject to risks, uncertainties and assumptions about Livent, may include projections of Livent's future financial performance, Livent's anticipated growth strategies and anticipated trends in Livent's business, including without limitation, our capital expansion plans and development of the Nemaska project, including expectations around production timelines, and the anticipated timing for, and outcome and effects of, the proposed merger with Allkem. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the Company based on currently available information. There are important factors that could cause Livent's actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including the factors described under the caption entitled "Risk Factors" in Livent's 2022 Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 24, 2023 as well as other SEC filings and public communications. Although Livent believes the expectations reflected in the forward-looking statements are reasonable, Livent cannot guarantee future results, level of activity, performance or achievements. Moreover, neither Livent nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Livent is under no duty to update any of these forward-looking statements after the date of this news release to conform its prior statements to actual results or revised expectations. Non-GAAP Financial Terms In these slides, Livent uses the financial measures Adjusted EBITDA, adjusted EPS and adjusted cash from operations. These terms are not calculated in accordance with generally accepted accounting principles (GAAP). Definitions of these terms, as well as a reconciliation to the most directly comparable financial measure calculated and presented in accordance with GAAP, are provided on our website ir.livent.com. 2#3Livent Highlights ● ● ● ● Reports Higher Adjusted EBITDA Versus Prior Year Provdes Update on the Progress of Capacity Expansions Releases Feasibility Study for Nemaska Lithium Project Merger of Equals with Allkem Remains on Track to Close Around Year End 32#4Livent Reported Financial Results Q3 2023 Q2 2023 Revenue GAAP Net Income (Loss) Adjusted EBITDA (¹) GAAP EPS Adjusted EPS (1) $211 $87 $120 42¢ 44¢ $236 $90 $135 43¢ 51¢ QoQ Down 10% Down 3% Down 11% Down 2% Down 14% Q3 2022 $232 $78 $111 37¢ 41¢ YoY Down 9% Up 13% Up 8% Up 14% Up 7% Note: Amounts in millions of USD, except earnings per diluted share. Percentages calculated on reported results rounded to nearest decimal. (1) Denotes non-GAAP financial term. 4#5Livent Full Year 2023 Guidance Revenue Adjusted EBITDA (1) Note: Amounts in millions of USD. (1) Denotes non-GAAP financial term. Full Year 2023E Guidance $890 - $940 $500 $530 Prior Full Year 2023E Guidance $1,025 - $1,125 $530 - $600 Full Year 2022A $813 $367 Guidance Versus 2022A (midpoint) Up 13% Up 40% LO 5#6#7#8#9#10#11#12#13#14#15